Skip to main content
Year archive

JW PHARMACEUTICAL — 2025 filings

All 32 regulatory filings released by JW PHARMACEUTICAL (001060) in 2025, sourced directly from the official regulator.

32 Filings
2025 Period
2025 filings (32)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2025-12-16 Korean
기타경영사항(자율공시) (배당기준일 변경 안내)
Notice of Dividend Amount
2025-12-16 Korean
영업(잠정)실적(공정공시)
Regulatory Filings
2025-11-03 Korean
[기재정정]타인에대한채무보증결정
Regulatory Filings
2025-10-02 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Q2 2025
2025-07-31 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2025-07-31 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2025-07-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-07-01 Korean
자기주식취득결과보고서
Transaction in Own Shares
2025-06-25 Korean
벌금등의부과
Legal Proceedings Report
2025-06-13 Korean
기업지배구조보고서공시
Governance Information
2025-05-30 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2025
2025-05-07 Korean
기업가치제고계획(자율공시) (2025년)
Management Reports
2025-04-21 Korean
최대주주등소유주식변동신고서
Director's Dealing
2025-04-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2025-03-26 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares
2025-03-24 Korean
자기주식취득결과보고서
Transaction in Own Shares
2025-03-19 Korean
사업보고서 (2024.12)
Audit Report / Information FY 2024
2025-03-18 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-11 Korean
타법인주식및출자증권취득결정
M&A Activity
2025-03-06 Korean
유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change
2025-03-06 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2025-02-11 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2025-02-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2025-02-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2024
2025-02-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-01-07 Korean